Clifford Swan Investment Counsel Cut Abbott Labs (ABT) Stake; Ejf Capital Trimmed Its Zions Bancorporation (ZION) Position

January 14, 2018 - By wolcottdaily

Ejf Capital Llc decreased Zions Bancorporation (ZION) stake by 45.45% reported in 2017Q3 SEC filing. Ejf Capital Llc sold 801,904 shares as Zions Bancorporation (ZION)’s stock declined 10.19%. The Ejf Capital Llc holds 962,339 shares with $45.40 million value, down from 1.76M last quarter. Zions Bancorporation now has $10.64B valuation. The stock increased 0.32% or $0.17 during the last trading session, reaching $53.28. About 1.63 million shares traded. Zions Bancorporation (NASDAQ:ZION) has risen 48.85% since January 14, 2017 and is uptrending. It has outperformed by 32.15% the S&P500.




Clifford Swan Investment Counsel Llc decreased Abbott Labs (ABT) stake by 1.85% reported in 2017Q3 SEC filing. Clifford Swan Investment Counsel Llc sold 6,094 shares as Abbott Labs (ABT)’s stock declined 3.42%. The Clifford Swan Investment Counsel Llc holds 323,529 shares with $17.26 million value, down from 329,623 last quarter. Abbott Labs now has $102.42 billion valuation. The stock decreased 0.19% or $0.11 during the last trading session, reaching $58.84. About 6.32M shares traded or 6.93% up from the average. Abbott Laboratories (NYSE:ABT) has risen 15.90% since January 14, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.

Among 30 analysts covering Zions Bancorporation (NASDAQ:ZION), 16 have Buy rating, 1 Sell and 13 Hold. Therefore 53% are positive. Zions Bancorporation had 113 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by BMO Capital Markets with “Hold” on Monday, December 18. The stock of Zions Bancorporation (NASDAQ:ZION) earned “Buy” rating by Compass Point on Wednesday, March 29. Susquehanna maintained the shares of ZION in report on Thursday, January 4 with “Hold” rating. The stock of Zions Bancorporation (NASDAQ:ZION) has “Overweight” rating given on Thursday, January 5 by JP Morgan. Bernstein downgraded Zions Bancorporation (NASDAQ:ZION) on Wednesday, November 16 to “Mkt Perform” rating. The stock of Zions Bancorporation (NASDAQ:ZION) earned “Buy” rating by Goldman Sachs on Wednesday, September 16. The rating was maintained by Barclays Capital on Tuesday, October 24 with “Overweight”. The rating was downgraded by Evercore to “Hold” on Tuesday, April 26. Keefe Bruyette & Woods downgraded Zions Bancorporation (NASDAQ:ZION) on Tuesday, October 25 to “Mkt Perform” rating. As per Tuesday, April 26, the company rating was maintained by JP Morgan.

Since August 4, 2017, it had 0 buys, and 5 selling transactions for $1.56 million activity. James Dianne R sold $71,674 worth of Zions Bancorporation (NASDAQ:ZION) on Tuesday, August 15. Young Mark Richard sold $764,781 worth of stock or 15,000 shares. $46,375 worth of stock was sold by LAURSEN THOMAS E on Friday, August 4. Shares for $584,717 were sold by Schreiber Edward on Monday, August 14.

Analysts await Zions Bancorporation (NASDAQ:ZION) to report earnings on January, 22. They expect $0.74 EPS, up 23.33% or $0.14 from last year’s $0.6 per share. ZION’s profit will be $147.81 million for 18.00 P/E if the $0.74 EPS becomes a reality. After $0.72 actual EPS reported by Zions Bancorporation for the previous quarter, Wall Street now forecasts 2.78% EPS growth.

Investors sentiment decreased to 1.05 in Q3 2017. Its down 0.04, from 1.09 in 2017Q2. It dived, as 45 investors sold ZION shares while 132 reduced holdings. 54 funds opened positions while 131 raised stakes. 181.27 million shares or 1.35% less from 183.76 million shares in 2017Q2 were reported. 45,747 are owned by Glg Limited Liability. Dnb Asset Mgmt As invested 0.01% in Zions Bancorporation (NASDAQ:ZION). Tiaa Cref Inv Mngmt Ltd Llc invested in 0.11% or 3.35M shares. New Jersey-based Jacobs Levy Equity Mgmt has invested 0.26% in Zions Bancorporation (NASDAQ:ZION). Tarbox Family Office accumulated 61 shares or 0% of the stock. Westpac Banking has 0.05% invested in Zions Bancorporation (NASDAQ:ZION). Moreover, Morgan Stanley has 0.01% invested in Zions Bancorporation (NASDAQ:ZION) for 765,698 shares. Redwood Invs Lc holds 1.31% or 244,012 shares. Norinchukin Fincl Bank The holds 8,997 shares. Petrus Tru Lta holds 4,773 shares. Sheets Smith Wealth Mngmt accumulated 30,774 shares. Maltese Cap Mgmt Limited Liability Company holds 477,400 shares or 1.93% of its portfolio. 1.00 million were reported by Legal General Gru Inc Public Ltd. Caisse De Depot Et Placement Du Quebec has invested 0% in Zions Bancorporation (NASDAQ:ZION). Louisiana State Employees Retirement System stated it has 12,600 shares or 0.03% of all its holdings.

Clifford Swan Investment Counsel Llc increased Johnson Controls International stake by 34,968 shares to 205,216 valued at $8.27M in 2017Q3. It also upped Franklin K2 Alternative Strate stake by 33,807 shares and now owns 94,918 shares. Schlumberger Ltd (NYSE:SLB) was raised too.

Since August 1, 2017, it had 0 buys, and 6 selling transactions for $22.86 million activity. Another trade for 96,603 shares valued at $5.43M was made by Salvadori Daniel Gesua Sive on Monday, October 23. $98,323 worth of Abbott Laboratories (NYSE:ABT) shares were sold by Bracken Sharon J. Contreras Jaime also sold $2.74 million worth of Abbott Laboratories (NYSE:ABT) shares. 196,550 shares were sold by Fussell Stephen R, worth $9.73 million.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 92 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Abbott Laboratories (NYSE:ABT) has “Hold” rating given on Thursday, August 17 by Citigroup. The company was upgraded on Tuesday, January 2 by Morgan Stanley. The firm earned “Buy” rating on Friday, February 5 by Argus Research. On Thursday, August 31 the stock rating was maintained by BMO Capital Markets with “Hold”. The firm has “Hold” rating by BMO Capital Markets given on Thursday, July 20. The firm has “Buy” rating by Jefferies given on Tuesday, June 14. The stock has “Buy” rating by Cowen & Co on Monday, April 17. The rating was upgraded by Edward Jones to “Buy” on Tuesday, June 21. RBC Capital Markets maintained the stock with “Buy” rating in Monday, October 2 report. The company was maintained on Tuesday, October 10 by Jefferies.

Investors sentiment decreased to 0.87 in 2017 Q3. Its down 0.01, from 0.88 in 2017Q2. It worsened, as 47 investors sold ABT shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 were reported. Alesco Advsr Ltd Liability reported 4,599 shares or 0.02% of all its holdings. 5,685 are owned by Obermeyer Wood Invest Counsel Lllp. Rbf Cap Ltd Llc reported 10,000 shares. Moreover, Farmers Merchants Investments Inc has 0.52% invested in Abbott Laboratories (NYSE:ABT) for 124,219 shares. 4,134 were reported by Wallace Cap. Barrington Strategic Wealth Management Group Limited Liability Com holds 0.4% of its portfolio in Abbott Laboratories (NYSE:ABT) for 14,713 shares. Moreover, Whitnell & has 1.12% invested in Abbott Laboratories (NYSE:ABT). Madison Invest Inc reported 3,780 shares or 0% of all its holdings. Peregrine Asset Advisers Inc stated it has 4,500 shares or 0.13% of all its holdings. Public Employees Retirement Sys Of Ohio reported 1.25 million shares. South State holds 0.39% of its portfolio in Abbott Laboratories (NYSE:ABT) for 65,717 shares. North Star Inv Mgmt, a Illinois-based fund reported 69,550 shares. Amg National Trust Bancshares owns 57,297 shares. Reliance Trust Of Delaware invested 0.15% in Abbott Laboratories (NYSE:ABT). 22,740 are held by Excalibur Management Corp.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: